Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.
Phase of Trial: Phase II/III
Latest Information Update: 13 Feb 2017
At a glance
- Drugs Rosiglitazone (Primary) ; Simvastatin (Primary)
- Indications Metabolic syndrome; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms SIROCO
- 27 Feb 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2012 Results published in Diabetes, Obesity and Metabolism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History